You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine Visit targeted treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumococcal Vaccines, Immunization Coverage Trial (Enhanced reminders, Standard CANImmunize notifications)

Not yet recruiting
  • Pneumococcal Vaccines
  • Immunization Coverage
  • Enhanced reminders
  • Standard CANImmunize notifications
  • (no location specified)
Aug 14, 2023

Hypertension, Type 2 Diabetes Trial in Dallas (Home visit)

Recruiting
  • Hypertension
  • Type 2 Diabetes
  • Home visit
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 23, 2022

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Pneumonia, Influenza, Varicella Zoster Trial (Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and

Not yet recruiting
  • Pneumonia
  • +5 more
  • Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination
  • (no location specified)
Oct 4, 2023

NSCLC Trial in Baltimore (Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides
  • Baltimore, Maryland
    Johns Hopkins University
Jun 16, 2022

High Risk Cancer, Pancreatic Cancer Trial in Baltimore (KRAS peptide vaccine)

Recruiting
  • High Risk Cancer
  • Pancreatic Cancer
  • KRAS peptide vaccine
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jun 1, 2022

Pancreas Cancer Trial in Montpellier (Biological/Vaccine: Blood sample and tissue sample)

Not yet recruiting
  • Pancreas Cancer
  • Biological/Vaccine: Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Nov 23, 2023

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

Recruiting
  • Diffuse Large-Cell Lymphoma
  • +3 more
  • Pneumococcal conjugate vaccine (PCV13)
  • CD19 targeted CAR T Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
May 31, 2022

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)

Active, not recruiting
  • Mesothelioma
  • +2 more
  • Galinpepimut-S
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Nov 23, 2022

Herpes Zoster Trial in Hong Kong (recombinant subunit herpes zoster vaccine)

Not yet recruiting
  • Herpes Zoster
  • recombinant subunit herpes zoster vaccine
  • Hong Kong, China
    Department of Medicine, Tuen Mun Hospital
Dec 18, 2021

Covid19, Vaccine Refusal Trial in Boston (Messaging informed by construal level theory, Usual Care)

Active, not recruiting
  • Covid19
  • Vaccine Refusal
  • Messaging informed by construal level theory
  • Usual Care
  • Boston, Massachusetts
    Mass General Brigham
Jun 2, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

Withdrawn
  • Covid19
  • hAd5-S-Fusion+N-ETSD vaccine
  • (no location specified)
Dec 14, 2021

Covid19 Trial (hAd5-S-Fusion+N-ETSD vaccine)

Withdrawn
  • Covid19
  • hAd5-S-Fusion+N-ETSD vaccine
  • (no location specified)
Dec 14, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

Recruiting
  • Recurrent Neuroblastoma
  • +3 more
  • Palo Alto, California
  • +3 more
Jan 25, 2023

Immune Amnesia Following Measles Infection in Select African

Not yet recruiting
  • Measles Infection
  • Verorab
  • Conakry, Guinea
  • +1 more
Nov 29, 2023

Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

Completed
  • Dengue
  • LD vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health, (Unisante)
Nov 28, 2022

Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

Completed
Has Results
  • Neoplasms
  • +4 more
  • ETBX-051; adenoviral brachyury vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 25, 2020

HPV Trial in Gainesville (Brief Provider Training - Bundled Approach, Brief Provider Training - Benefits Approach, Parent

Recruiting
  • HPV
  • Brief Provider Training - Bundled Approach
  • +3 more
  • Gainesville, Florida
    University of Florida
Jun 30, 2022